Medical Xpress - Cardiology

APRIL 10, 2024

A new study reveals diminished quality of life among patients with chronic limb-threatening ischemia, a severe form of peripheral artery disease, and emphasizes the benefits of revascularization on well-being.

Quality of Life 40

Quality of Life Ischemia Peripheral Arterial Disease 40

Med Page Today

APRIL 30, 2024

(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Angioplasty Heart Disease Cancer 64

DAIC

MARCH 27, 2024

Food and Drug Administration (FDA) for its DynamX BTK System, a novel, adaptive implant for use in the treatment of narrowed or blocked vessels below-the-knee (BTK) in patients with chronic limb-threatening ischemia (CLTI). Peripheral arterial disease ( PAD ) affects more than 200 million people worldwide. Glob Heart.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Ischemia Technology Coronary Artery Disease 111

CardiacWire

MAY 10, 2024

A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheral artery disease surgeries has a massive impact on coronary artery disease detection, treatments, and long-term outcomes.

Coronary Artery Disease 59

Coronary Artery Disease Peripheral Arterial Disease Ischemia Myocardial Infarction 59

American College of Cardiology

JUNE 3, 2024

The new 2024 Guideline on the Management of Lower Extremity Peripheral Artery Disease (PAD) released by the ACC and the American Heart Association (AHA) offers the latest, evidence-based recommendations to guide clinicians in the diagnosis and treatment of lower extremity PAD across its four clinical presentation subsets: asymptomatic disease, chronic (..)

Peripheral Arterial Disease 40

Peripheral Arterial Disease Document Ischemia Article 40

DAIC

FEBRUARY 14, 2024

The Efemoral Vascular Scaffold System (EVSS) offers a new approach to treating peripheral arterial occlusive disease (PAOD) by addressing the specific anatomic challenges and complex biomechanics of patients with athero-occlusive disease in the leg. The global burden of peripheral artery disease.

Heart Attack 111

Heart Attack Heart attacks Peripheral Arterial Disease Ischemia 111

DAIC

SEPTEMBER 16, 2024

The Shockwave E 8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI). PAD affects more than eight million people aged 40 and older in the United States.

52

52

Circulation

OCTOBER 18, 2023

BACKGROUND:Rivaroxaban plus aspirin compared with aspirin alone reduced major cardiac and ischemic limb events after lower extremity revascularization (LER) in the VOYAGER PAD (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) trial.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Myocardial Infarction Thrombolysis Ischemia 40

DAIC

MARCH 20, 2024

The Freesolve BTK RMS is designed for individuals suffering from chronic limb-threatening ischemia (CLTI). CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Coronary Artery Disease Technology 105

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. Journal of Vascular Surgery, Mar.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Myocardial Infarction Ischemia 111

Frontiers in Cardiovascular Medicine

JULY 2, 2024

BackgroundPeripheral artery disease (PAD) is on the rise worldwide, ranking as the third leading cause of atherosclerosis-related morbidity; much less is known about its trends in hospitalizations among methamphetamine and cocaine users.ObjectivesWe aim to evaluate the overall trend in the prevalence of hospital admission for PAD with or without the (..)

Peripheral Arterial Disease 52

Peripheral Arterial Disease Hospital Ischemia Inpatient 52

DAIC

MAY 30, 2024

The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5%

Stents 69

Stents Stent Peripheral Arterial Disease Innovation 69

Dr. Anish Koka

MAY 16, 2023

years of age, P <0.001), cerebral or peripheral artery disease (6.2% While cardiologists have always recognized the presence of disease in the smaller arteries (microvascular disease), the presence of significant microvascular disease in the absence of epicardial disease is thought to be fairly rare.

Chest Pain 52

Chest Pain Coronary Artery Disease Cancer Heart Attack 52

DAIC

JANUARY 23, 2024

21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and sudden cardiac death among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22 12 Colchicine, 0.5

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111